Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.

Autor: Katunina AI; N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia., Gershtein ES, Ermilova VD, Tereshkina IV, Nazarenko AY, Tyleuova AA, Dvorova EK, Karabekova ZK, Gritskevich MV, Berezov TT

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2011 Jul; Vol. 151 (3), pp. 359-62.

Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.

Autor: Gerstein ES; N. N. Blokhin Cancer Research Center, Moscow, Russia. esgerstein@gmail.com, Sini L, Ryabov AB, Dvorova EK, Yurchenko AA, Stilidi IS, Kushlinskii NE, Davydov MI

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2009 Dec; Vol. 148 (6), pp. 899-902.

Expression of biomolecular markers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in breast tumors.

Autor: Kushlinskii NE; N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow; M. F. Vladimirskii Moscow Regional Research and Clinical Institute., Orinovskii MB, Gurevich LE, Kazantseva IA, Talaeva ShZh, Shirokii VP, Ermilova VD, Dvorova EK, Ozherelev AS

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2004 Feb; Vol. 137 (2), pp. 182-5.

[Epidermal growth factor receptors and their ligands as molecular markers of breast cancer prognosis and hormone sensitivity].

Autor: Gershteĭn ES, Kushlinskiĭ NE, Dvorova EK, Kostyleva OI, Muaviia MA, Letiagin VP

Publikováno v: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 1998 Feb (2), pp. 9-13.

[Prognosis in fibrosarcoma of bone].

Autor: Petrovichev NN, Annamukhammedov A, Zatsepin ST, Lipkin SI, Dvorova EK

Publikováno v: Voprosy onkologii [Vopr Onkol] 1988; Vol. 34 (2), pp. 157-62.